Cell Ply Announces Emiliano Spagnolo As the New CEO
07/27/23, 5:05 AM
Location
bologna
Industry
artificial intelligence
biotechnology
Position
chief executive officer
Former Comecer exec succeeds current Chief Executive Officer and founder Massimo Bocchi to lead the next phase of commercial expansion
CellPly, the pioneer in multiparametric single-cell analysis and automated potency testing for cell therapy, today announced the appointment of Emiliano Spagnolo to the role of CEO, starting from July 14, 2023. Spagnolo joins CellPly after 15 years at Comecer Group, a company commercializing automated solutions for pharmaceutical products manufacturing, including Advanced Therapeutics Medicinal Products , where he drove above-market growth for multiple business lines. Spagnolo succeeds current CellPly CEO and founder Massimo Bocchi, who will be moving into a Chief Strategy Officer role with the company.
Company Info
Location
bologna, emilia-romagna, italy
Additional Info
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics.
Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments.
Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.